ArticleCase reports in obstetrics and gynecology2025
A Rare Case of Müllerian Agenesis With a Giant Tumor Arising From Uterine Remnants.
Article in Case reports in obstetrics and gynecology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Rare Case of Müllerian Agenesis With a Giant Tumor Arising From Uterine Remnants.Case reports in obstetrics and gynecology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Müllerian agenesis, also known as vaginal agenesis, Müllerian aplasia, or Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome, is a rare developmental disorder affecting one in 5000 female births, resulting from an error in Müllerian duct fusion during fetal development. Case Report: We present a clinical case of a 46-year-old female patient, virgo intacta, with Müllerian agenesis and a leiomyoma arising from remnant uterine buds. The patient presented with primary amenorrhoea, continuous lower abdominal pain, and abdominal distension. We describe the diagnostic process and treatment strategy. Discussion: MRKH syndrome is the leading cause of vaginal agenesis, often accompanied by uterine and cervical aplasia. It is categorized into Type 1, which involves symmetric underdevelopment of the Müllerian ducts, and Type 2, characterized by asymmetric malformations of the genital tract and other congenital anomalies. Leiomyomas arising from remnant uterine tissue in MRKH patients are extremely rare. Accurate diagnosis and a carefully planned treatment strategy are essential for managing patients with MRKH syndrome complicated by rare tumors. Conclusion: In this case, total tumor extirpation with bilateral adnexectomy was the preferred treatment, based on the patient's clinical presentation and diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.